The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $88.68

Today's change-0.11 -0.12%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $88.68

Today's change-0.11 -0.12%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.

Reversal following new 52-week high

ResMed Inc closed lower Friday, dropping (U.S.)$0.11 or 0.12% to (U.S.)$88.68 after setting a new 52-week high. Over the last five days, shares have gained 1.03% and are currently 1.16% off of its 52-week high. Over the last year, this stock has outperformed the S&P 500, gaining 40.99%.

Key company metrics

  • Open(U.S.) $89.21
  • Previous close(U.S.) $88.79
  • High(U.S.) $89.72
  • Low(U.S.) $88.51
  • Bid / Ask-- / --
  • YTD % change+4.71%
  • Volume855,115
  • Average volume (10-day)539,045
  • Average volume (1-month)504,588
  • Average volume (3-month)591,431
  • 52-week range(U.S.) $62.64 to (U.S.) $89.72
  • Beta0.78
  • Trailing P/E35.94×
  • P/E 1 year forward29.23×
  • Forward PEG2.88×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.58%
  • Trailing EPS(U.S.) $2.47
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2018Q4/2017Q3/2017Q2/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue524557514530
Total other revenue--------
Total revenue524557514530
Gross profit306324300309
Total cost of revenue218233214221
Total operating expense411429407434
Selling / general / administrative144148138139
Research & development37373538
Depreciation / amortization12121112
Interest expense (income), net operating--------
Unusual expense (income)--0823
Other operating expenses, total--------
Operating income11312710797
Interest income (expense), net non-operating-8------
Gain (loss) on sale of assets--------
Other--------
Income before tax10812210896
Income after tax861028877
Income tax, total22202019
Net income861028877
Total adjustments to net income--------
Net income before extra. items861028877
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items861028877
Inc. avail. to common incl. extra. items861028877
Diluted net income861028877
Dilution adjustment--------
Diluted weighted average shares143143143142
Diluted EPS excluding extraordinary itemsvalue per share0.600.710.620.54
Dividends per sharevalue per share0.350.330.330.33
Diluted normalized EPSvalue per share0.600.710.660.67